Clinical Trial Update: Levetiracetam in Early Psychosis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating levetiracetam in early psychosis has been completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: NYU Langone Health | Conditions: Psychosis, Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2022-11-21